"El desarrollo de la ciencia aplicada a la salud no entiende de días de fiesta"
Diario de Sevilla
26/12/2010, Seville

I encourage all women with fibroids to be informed of this technique before to perform any other invasive procedure

It was quick, easy, painless, and I never have any trouble.
Cartuja Institute is the first and only center in Spain to offer his patients the new non-invasive surgery technology with focused ultrasound guided by magnetic resonance imaging (MRgFUS technology).
At present, the technology is available in some 80 centers worldwide. These centers include, in Europe, the Hospital St. Mary's with Imperial College London Clinic Charité University Von Humboldt in Berlin and the United States, Brigham Women's Hospital, Harvard Medical School, Mayo Clinic, Rochester, Weill Medical College, University of California San Diego, Cornell University and others. To date, more than 5,500 patients have been treated by MRgFUS technology.
MRgFUS technology is a new technology of "non-invasive surgery image-guided. " It applies to the treatment of tumors by focusing ultrasound beam safe guided by an MRI. Does not require hospitalization or general anesthesia and the patient can return to normal activity the next day.

It is a surgery technology
noninvasive image-guided
Used to treat some types
tumors. . Today
is available for the treatment
uterine fibroids and for
palliative treatment of pain en
bone metastases
Applied from outside
patient's body
Do not use any type of radiation,
but harmless ultrasound
Planning, monitoring and evaluation
treatment are made in 3D
real-time MRI magnetic
It does not require general
anesthesia, but conscious sedation
Does not require hospitalization
Instituto Cartuja Corporación S.A. - C/ Américo Vespucio, 45 · Isla de la Cartuja · 41092 · Sevilla · Tel. 902 550 185 Legal Conditions
Web Design YCP